Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reference values for leptin/adiponectin ratio in healthy children and adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Extracellular Polysaccharide Matrix of Pseudomonas aeruginosa Biofilms Is a Determinant of Polymorphonuclear Leukocyte Responses

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Protein array-based companion diagnostics in precision medicine

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Citrullination is the post-translational conversion of arginine into citrulline in proteins. The reaction is catalyzed by peptidylarginine deiminase (PAD), of which five isoforms exist. Fibrinogen is a substrate for PAD2 and PAD4, and citrullinated fibrinogen (cFBG) has been detected in patients with inflammatory diseases. In purified systems, cFBG is known to inhibit the release of fibrinopeptide A (FPA) and B (FPB) and impairs fibrin polymerization. However, the effect of cFBG on fibrin structure and fibrinolysis in a plasma environment remains unclear. We hypothesized that citrullination of fibrinogen impairs fibrin properties.

METHODS: Fibrinogen was citrullinated by recombinant PAD2 and PAD4. The impact of cFBG on fibrin structure was investigated by turbidity measurements in fibrinogen-deficient plasma spiked with cFBG or native fibrinogen.

RESULTS: Citrullination of fibrinogen by PAD2 dose-dependently reduced the rate of fibrin polymerization, as well as the overall hemostasis potential of fibrin, the maximum velocity of fibrin formation, the fibrin mass/length ratio, and the lysis of fibrin clots.

CONCLUSION: Citrullination of fibrinogen by PAD2 affects not only fibrin polymerization but also fibrin fiber properties, indicating that the fibrin network formed in the presence of cFBG may influence hemostasis. Our results suggest that citrullination of fibrinogen alters the composition of fibrin fibers which may lead to a looser fibrin network that is more susceptible to fibrinolysis and thereby affecting the hemostatic balance.

Original languageEnglish
JournalClinica chimica acta; international journal of clinical chemistry
Volume501
Pages (from-to)6-11
Number of pages6
ISSN0009-8981
DOIs
Publication statusPublished - Feb 2020

    Research areas

  • Citrullination, Fibrin/chemistry, Fibrinogen/chemistry, Humans, Protein Conformation, Protein-Arginine Deiminase Type 2/chemistry

ID: 61866213